| Operating activities: | |
| Net (loss) income | 7.23M |
| Adjustments to reconcile net (loss) income to net cash (used in) / provided by operating activities: | |
| Depreciation and amortization | 1.63M |
| Stock-based compensation | 571.81K |
| Other-than-temporary impairment | |
| Impairment loss on real estate owned | |
| Gain on extinguishment of debt | -3.76M |
| Loss on sale of securities | |
| Provision for loan losses (net of recoveries) | 2.5M |
| Loss on restructured loans | |
| Amortization and accretion of interest and fees | -214.66K |
| Change in fair value of non-qualifying swaps | -107.72K |
| (Income) loss from equity affiliates | 81.89K |
| Changes in operating assets and liabilities: | |
| Other assets | 14K |
| Distributions of operations from equity affiliates | 24.37K |
| Other liabilities | -4.16M |
| Change in restricted cash | 239.97K |
| Due to/from related party | -2.19M |
| Net cash (used in) / provided by operating activities | 1.86M |
| Investing activities: | |
| Loans and investments funded, originated and purchased, net | -101.35M |
| Payoffs and paydowns of loans and investments | 34.73M |
| Deposits received relating to loan held-for-sale | |
| Proceeds from sale of loans | |
| Due to borrowers and reserves | -585.14K |
| Change in restricted cash | |
| Deferred fees | 515.22K |
| Purchase of securities | |
| Principal collection on securities | |
| Proceeds from sale of available-for-sale securities | |
| Investment in real estate, net | -2.8M |
| Proceeds from investments in real estate owned, net | |
| Contributions to equity affiliates | |
| Distributions from equity affiliates | |
| Net cash (used in) / provided by investing activities | -82.37M |
| Financing activities: | |
| Proceeds from loan participations and notes payable | 23.7M |
| Paydowns of mortgage notes payable - real estate owned | 0 |
| Payoffs and paydowns of repurchase agreements and notes payable | -104.96M |
| Payoff of junior subordinated notes to subsidiary trust issuing preferred securities | |
| Proceeds from collateralized debt obligations | |
| Payoffs and paydowns of collateralized debt obligations | |
| Change in restricted cash | -29.77M |
| Payments on swaps to hedge counterparties | -20.64M |
| Receipts on swaps from hedge counterparties | 22.55M |
| Purchases of treasury stock | 0 |
| Distributions paid to noncontrolling interest | -50.17K |
| Distributions paid on preferred stock of private REIT | -4.13K |
| Payment of deferred financing costs | -3.1M |
| Net cash used in financing activities | 129.29M |
| Net decrease in cash and cash equivalents | 48.78M |
| Cash and cash equivalents at beginning of period | 29.19M |
| Cash and cash equivalents at end of period | 77.96M |
| Supplemental cash flow information: | |
| Cash used to pay interest | 13.09M |
| Cash used for taxes | 108.59K |
| Supplemental schedule of non-cash investing and financing activities: | |
| Loans transferred to real estate owned, net | |
| Assumption of mortgage note payable - real estate owned | |
| Issuance of common stock for management incentive fee | |
| Extinguishment of notes payable | |
| Extinguishment of trust preferred securities | |
| Re-issuance of CDO debt | |
| Accrual of interest on reissued collateralized debt obligations | |
| Available-for-sale securities exchanged | |
| Investments transferred to available-for-sale securities, at fair value | |
| Loan payoffs and paydowns received by related party | |